Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 213
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07040228 | A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer | ||
| NCT04213105 | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults | ||
| NCT03435666 | A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition | ||
| NCT06754644 | A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC | ||
| NCT04859751 | Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer | ||
| NCT06823609 | Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors | ||
| NCT07358858 | A Food Effect Study of QLS1410 in Healthy Chinese Adults | ||
| NCT07358884 | First in Human Study of QLS5316 in Solid Tumors | ||
| NCT07041788 | Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC | ||
| NCT05823285 | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients | ||
| NCT03651947 | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults | ||
| NCT07079228 | A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer | ||
| NCT06232902 | A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers | ||
| NCT07001839 | A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus | ||
| NCT07348861 | A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer | ||
| NCT07173595 | A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies | ||
| NCT07453394 | QLS5132 Combination Therapy in Advanced Solid Tumors | ||
| NCT06954116 | Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence | ||
| NCT07198633 | A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer | ||
| NCT06799559 | Study on the Efficacy and Safety of QLM1016 in Schizophrenia | ||
| NCT06742138 | To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma | ||
| NCT06613880 | Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia | ||
| NCT07327619 | A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP | ||
| NCT02335879 | Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation | ||
| NCT05976568 | A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT05055687 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD) | ||
| NCT07417917 | QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa | ||
| NCT07018050 | Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma | ||
| NCT06261359 | A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma | ||
| NCT05860530 | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers | ||
| NCT07178171 | A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC | ||
| NCT05345236 | A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) | ||
| NCT07089186 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections | ||
| NCT06406205 | A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis | ||
| NCT06047431 | A Study of QL1706H in Patients With Advanced Solid Tumors | ||
| NCT05801094 | A Phase I Study of QL1604 for Advanced Solid Tumors | ||
| NCT05851027 | Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia | ||
| NCT06173011 | A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults | ||
| NCT07138833 | A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS) | ||
| NCT06151587 | A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children | ||
| NCT06936748 | SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors | ||
| NCT05576272 | A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma | ||
| NCT06633718 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI | ||
| NCT05649761 | A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors | ||
| NCT06954246 | A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer | ||
| NCT07062978 | A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® | ||
| NCT07040826 | Lifitegrast Eye Drops in Healthy Subjects：Phase I Study | ||
| NCT03770624 | A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA | ||
| NCT05458076 | A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants | ||
| NCT05932888 | Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects |
